The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Global Neurodegenerative Disease Market Research Report 2025
Synopsis
Neurodegenerative diseases are a group of disorders characterized by the progressive degeneration of the structure and function of the nervous system, leading to cognitive and motor impairments. Examples include Alzheimer's disease, Parkinson's disease, and amyotrophic lateral sclerosis (ALS).
The global Neurodegenerative Disease market was valued at US$ 7003.2 million in 2023 and is anticipated to reach US$ 8704 million by 2030, witnessing a CAGR of 3.1% during the forecast period 2024-2030.
The market for neurodegenerative disease treatments and management is driven by the increasing prevalence of these diseases, particularly with an aging population. The market's growth is also influenced by the demand for disease-modifying therapies and symptom management options to improve the quality of life for patients.
This report aims to provide a comprehensive presentation of the global market for Neurodegenerative Disease, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Neurodegenerative Disease.
Report Scope
The Neurodegenerative Disease market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Neurodegenerative Disease market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Neurodegenerative Disease companies, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Novartis
Pfizer
Merck Serono
Biogen Idec
TEVA
UCB
Boehringer Ingelheim
Sanofi
GlaxoSmithKline
Livzon Pharmaceutical
Haisco Pharmaceutical
Jingxin Pharmaceutical
Dongcheng Biochemicals
Hisun Pharmaceutical
Luye Pharma
Ark Pharmaceutical
Kanghong Pharmaceutical
Huahai Pharmaceutical
BORA PHARMACEUTICALS
Segment by Type
NMDA
SSRIs
Dopamine Inhibitors
Segment by Application
Parkinson’s Disease
Huntington Disease
Amyotrophic Lateral Sclerosis
Alzheimer’s Disease
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Neurodegenerative Disease companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
Neurodegenerative diseases are a group of disorders characterized by the progressive degeneration of the structure and function of the nervous system, leading to cognitive and motor impairments. Examples include Alzheimer's disease, Parkinson's disease, and amyotrophic lateral sclerosis (ALS).
The global Neurodegenerative Disease market was valued at US$ 7003.2 million in 2023 and is anticipated to reach US$ 8704 million by 2030, witnessing a CAGR of 3.1% during the forecast period 2024-2030.
The market for neurodegenerative disease treatments and management is driven by the increasing prevalence of these diseases, particularly with an aging population. The market's growth is also influenced by the demand for disease-modifying therapies and symptom management options to improve the quality of life for patients.
This report aims to provide a comprehensive presentation of the global market for Neurodegenerative Disease, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Neurodegenerative Disease.
Report Scope
The Neurodegenerative Disease market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Neurodegenerative Disease market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Neurodegenerative Disease companies, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Novartis
Pfizer
Merck Serono
Biogen Idec
TEVA
UCB
Boehringer Ingelheim
Sanofi
GlaxoSmithKline
Livzon Pharmaceutical
Haisco Pharmaceutical
Jingxin Pharmaceutical
Dongcheng Biochemicals
Hisun Pharmaceutical
Luye Pharma
Ark Pharmaceutical
Kanghong Pharmaceutical
Huahai Pharmaceutical
BORA PHARMACEUTICALS
Segment by Type
NMDA
SSRIs
Dopamine Inhibitors
Segment by Application
Parkinson’s Disease
Huntington Disease
Amyotrophic Lateral Sclerosis
Alzheimer’s Disease
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Neurodegenerative Disease companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
Index1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Neurodegenerative Disease Market Size Growth Rate by Type: 2019 VS 2023 VS 2030
1.2.2 NMDA
1.2.3 SSRIs
1.2.4 Dopamine Inhibitors
1.3 Market by Application
1.3.1 Global Neurodegenerative Disease Market Growth by Application: 2019 VS 2023 VS 2030
1.3.2 Parkinson’s Disease
1.3.3 Huntington Disease
1.3.4 Amyotrophic Lateral Sclerosis
1.3.5 Alzheimer’s Disease
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global Neurodegenerative Disease Market Perspective (2019-2030)
2.2 Neurodegenerative Disease Growth Trends by Region
2.2.1 Global Neurodegenerative Disease Market Size by Region: 2019 VS 2023 VS 2030
2.2.2 Neurodegenerative Disease Historic Market Size by Region (2019-2024)
2.2.3 Neurodegenerative Disease Forecasted Market Size by Region (2025-2030)
2.3 Neurodegenerative Disease Market Dynamics
2.3.1 Neurodegenerative Disease Industry Trends
2.3.2 Neurodegenerative Disease Market Drivers
2.3.3 Neurodegenerative Disease Market Challenges
2.3.4 Neurodegenerative Disease Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Neurodegenerative Disease Players by Revenue
3.1.1 Global Top Neurodegenerative Disease Players by Revenue (2019-2024)
3.1.2 Global Neurodegenerative Disease Revenue Market Share by Players (2019-2024)
3.2 Global Neurodegenerative Disease Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Neurodegenerative Disease Revenue
3.4 Global Neurodegenerative Disease Market Concentration Ratio
3.4.1 Global Neurodegenerative Disease Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Neurodegenerative Disease Revenue in 2023
3.5 Neurodegenerative Disease Key Players Head office and Area Served
3.6 Key Players Neurodegenerative Disease Product Solution and Service
3.7 Date of Enter into Neurodegenerative Disease Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Neurodegenerative Disease Breakdown Data by Type
4.1 Global Neurodegenerative Disease Historic Market Size by Type (2019-2024)
4.2 Global Neurodegenerative Disease Forecasted Market Size by Type (2025-2030)
5 Neurodegenerative Disease Breakdown Data by Application
5.1 Global Neurodegenerative Disease Historic Market Size by Application (2019-2024)
5.2 Global Neurodegenerative Disease Forecasted Market Size by Application (2025-2030)
6 North America
6.1 North America Neurodegenerative Disease Market Size (2019-2030)
6.2 North America Neurodegenerative Disease Market Growth Rate by Country: 2019 VS 2023 VS 2030
6.3 North America Neurodegenerative Disease Market Size by Country (2019-2024)
6.4 North America Neurodegenerative Disease Market Size by Country (2025-2030)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Neurodegenerative Disease Market Size (2019-2030)
7.2 Europe Neurodegenerative Disease Market Growth Rate by Country: 2019 VS 2023 VS 2030
7.3 Europe Neurodegenerative Disease Market Size by Country (2019-2024)
7.4 Europe Neurodegenerative Disease Market Size by Country (2025-2030)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Neurodegenerative Disease Market Size (2019-2030)
8.2 Asia-Pacific Neurodegenerative Disease Market Growth Rate by Region: 2019 VS 2023 VS 2030
8.3 Asia-Pacific Neurodegenerative Disease Market Size by Region (2019-2024)
8.4 Asia-Pacific Neurodegenerative Disease Market Size by Region (2025-2030)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Neurodegenerative Disease Market Size (2019-2030)
9.2 Latin America Neurodegenerative Disease Market Growth Rate by Country: 2019 VS 2023 VS 2030
9.3 Latin America Neurodegenerative Disease Market Size by Country (2019-2024)
9.4 Latin America Neurodegenerative Disease Market Size by Country (2025-2030)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Neurodegenerative Disease Market Size (2019-2030)
10.2 Middle East & Africa Neurodegenerative Disease Market Growth Rate by Country: 2019 VS 2023 VS 2030
10.3 Middle East & Africa Neurodegenerative Disease Market Size by Country (2019-2024)
10.4 Middle East & Africa Neurodegenerative Disease Market Size by Country (2025-2030)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Novartis
11.1.1 Novartis Company Detail
11.1.2 Novartis Business Overview
11.1.3 Novartis Neurodegenerative Disease Introduction
11.1.4 Novartis Revenue in Neurodegenerative Disease Business (2019-2024)
11.1.5 Novartis Recent Development
11.2 Pfizer
11.2.1 Pfizer Company Detail
11.2.2 Pfizer Business Overview
11.2.3 Pfizer Neurodegenerative Disease Introduction
11.2.4 Pfizer Revenue in Neurodegenerative Disease Business (2019-2024)
11.2.5 Pfizer Recent Development
11.3 Merck Serono
11.3.1 Merck Serono Company Detail
11.3.2 Merck Serono Business Overview
11.3.3 Merck Serono Neurodegenerative Disease Introduction
11.3.4 Merck Serono Revenue in Neurodegenerative Disease Business (2019-2024)
11.3.5 Merck Serono Recent Development
11.4 Biogen Idec
11.4.1 Biogen Idec Company Detail
11.4.2 Biogen Idec Business Overview
11.4.3 Biogen Idec Neurodegenerative Disease Introduction
11.4.4 Biogen Idec Revenue in Neurodegenerative Disease Business (2019-2024)
11.4.5 Biogen Idec Recent Development
11.5 TEVA
11.5.1 TEVA Company Detail
11.5.2 TEVA Business Overview
11.5.3 TEVA Neurodegenerative Disease Introduction
11.5.4 TEVA Revenue in Neurodegenerative Disease Business (2019-2024)
11.5.5 TEVA Recent Development
11.6 UCB
11.6.1 UCB Company Detail
11.6.2 UCB Business Overview
11.6.3 UCB Neurodegenerative Disease Introduction
11.6.4 UCB Revenue in Neurodegenerative Disease Business (2019-2024)
11.6.5 UCB Recent Development
11.7 Boehringer Ingelheim
11.7.1 Boehringer Ingelheim Company Detail
11.7.2 Boehringer Ingelheim Business Overview
11.7.3 Boehringer Ingelheim Neurodegenerative Disease Introduction
11.7.4 Boehringer Ingelheim Revenue in Neurodegenerative Disease Business (2019-2024)
11.7.5 Boehringer Ingelheim Recent Development
11.8 Sanofi
11.8.1 Sanofi Company Detail
11.8.2 Sanofi Business Overview
11.8.3 Sanofi Neurodegenerative Disease Introduction
11.8.4 Sanofi Revenue in Neurodegenerative Disease Business (2019-2024)
11.8.5 Sanofi Recent Development
11.9 GlaxoSmithKline
11.9.1 GlaxoSmithKline Company Detail
11.9.2 GlaxoSmithKline Business Overview
11.9.3 GlaxoSmithKline Neurodegenerative Disease Introduction
11.9.4 GlaxoSmithKline Revenue in Neurodegenerative Disease Business (2019-2024)
11.9.5 GlaxoSmithKline Recent Development
11.10 Livzon Pharmaceutical
11.10.1 Livzon Pharmaceutical Company Detail
11.10.2 Livzon Pharmaceutical Business Overview
11.10.3 Livzon Pharmaceutical Neurodegenerative Disease Introduction
11.10.4 Livzon Pharmaceutical Revenue in Neurodegenerative Disease Business (2019-2024)
11.10.5 Livzon Pharmaceutical Recent Development
11.11 Haisco Pharmaceutical
11.11.1 Haisco Pharmaceutical Company Detail
11.11.2 Haisco Pharmaceutical Business Overview
11.11.3 Haisco Pharmaceutical Neurodegenerative Disease Introduction
11.11.4 Haisco Pharmaceutical Revenue in Neurodegenerative Disease Business (2019-2024)
11.11.5 Haisco Pharmaceutical Recent Development
11.12 Jingxin Pharmaceutical
11.12.1 Jingxin Pharmaceutical Company Detail
11.12.2 Jingxin Pharmaceutical Business Overview
11.12.3 Jingxin Pharmaceutical Neurodegenerative Disease Introduction
11.12.4 Jingxin Pharmaceutical Revenue in Neurodegenerative Disease Business (2019-2024)
11.12.5 Jingxin Pharmaceutical Recent Development
11.13 Dongcheng Biochemicals
11.13.1 Dongcheng Biochemicals Company Detail
11.13.2 Dongcheng Biochemicals Business Overview
11.13.3 Dongcheng Biochemicals Neurodegenerative Disease Introduction
11.13.4 Dongcheng Biochemicals Revenue in Neurodegenerative Disease Business (2019-2024)
11.13.5 Dongcheng Biochemicals Recent Development
11.14 Hisun Pharmaceutical
11.14.1 Hisun Pharmaceutical Company Detail
11.14.2 Hisun Pharmaceutical Business Overview
11.14.3 Hisun Pharmaceutical Neurodegenerative Disease Introduction
11.14.4 Hisun Pharmaceutical Revenue in Neurodegenerative Disease Business (2019-2024)
11.14.5 Hisun Pharmaceutical Recent Development
11.15 Luye Pharma
11.15.1 Luye Pharma Company Detail
11.15.2 Luye Pharma Business Overview
11.15.3 Luye Pharma Neurodegenerative Disease Introduction
11.15.4 Luye Pharma Revenue in Neurodegenerative Disease Business (2019-2024)
11.15.5 Luye Pharma Recent Development
11.16 Ark Pharmaceutical
11.16.1 Ark Pharmaceutical Company Detail
11.16.2 Ark Pharmaceutical Business Overview
11.16.3 Ark Pharmaceutical Neurodegenerative Disease Introduction
11.16.4 Ark Pharmaceutical Revenue in Neurodegenerative Disease Business (2019-2024)
11.16.5 Ark Pharmaceutical Recent Development
11.17 Kanghong Pharmaceutical
11.17.1 Kanghong Pharmaceutical Company Detail
11.17.2 Kanghong Pharmaceutical Business Overview
11.17.3 Kanghong Pharmaceutical Neurodegenerative Disease Introduction
11.17.4 Kanghong Pharmaceutical Revenue in Neurodegenerative Disease Business (2019-2024)
11.17.5 Kanghong Pharmaceutical Recent Development
11.18 Huahai Pharmaceutical
11.18.1 Huahai Pharmaceutical Company Detail
11.18.2 Huahai Pharmaceutical Business Overview
11.18.3 Huahai Pharmaceutical Neurodegenerative Disease Introduction
11.18.4 Huahai Pharmaceutical Revenue in Neurodegenerative Disease Business (2019-2024)
11.18.5 Huahai Pharmaceutical Recent Development
11.19 BORA PHARMACEUTICALS
11.19.1 BORA PHARMACEUTICALS Company Detail
11.19.2 BORA PHARMACEUTICALS Business Overview
11.19.3 BORA PHARMACEUTICALS Neurodegenerative Disease Introduction
11.19.4 BORA PHARMACEUTICALS Revenue in Neurodegenerative Disease Business (2019-2024)
11.19.5 BORA PHARMACEUTICALS Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
